Julie Rubinstein
President and COO at Adaptive Biotechnologies. Based in Seattle, Washington.
- Rank
- 8406th of 14,644
- Companies held
- 1
- Largest holding
- ADPT, 100.0% of total
- Latest SEC filing
- Nov 13, 2026
What the $10.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies ADPT Common Stock | Directly | 377,802 | $28.05 | $10.6M | 100.0% | Form 4, Nov 13, 2026 |
Share counts are the amounts Julie Rubinstein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Sold | ADPT | 11,466 | $28.93 | $332K | View |
| Nov 12, 2026 | Sold | ADPT | 11,881 | $29.40 | $349K | View |
| Nov 11, 2026 | Sold | ADPT | 4,983 | $30.29 | $151K | View |
| Nov 11, 2026 | Sold | ADPT | 6,898 | $31.22 | $215K | View |
| Nov 10, 2026 | Sold | ADPT | 9,981 | $29.35 | $293K | View |
| Nov 10, 2026 | Sold | ADPT | 1,900 | $30.41 | $58K | View |
| Nov 9, 2026 | Sold | ADPT | 1,100 | $28.87 | $32K | View |
| Nov 9, 2026 | Sold | ADPT | 8,381 | $30.15 | $253K | View |
| Nov 9, 2026 | Sold | ADPT | 2,400 | $30.58 | $73K | View |
| Nov 6, 2026 | Sold | ADPT | 8,400 | $27.32 | $229K | View |
| Nov 6, 2026 | Sold | ADPT | 3,481 | $27.88 | $97K | View |
| Nov 5, 2026 | Sold | ADPT | 5,926 | $26.10 | $155K | View |
| Nov 5, 2026 | Sold | ADPT | 5,455 | $26.88 | $147K | View |
| Nov 5, 2026 | Sold | ADPT | 500 | $27.70 | $14K | View |
| Nov 4, 2026 | Sold | ADPT | 4,000 | $25.78 | $103K | View |
| Nov 4, 2026 | Sold | ADPT | 7,881 | $26.60 | $210K | View |
| Nov 3, 2026 | Sold | ADPT | 11,881 | $25.98 | $309K | View |
| Nov 2, 2026 | Sold | ADPT | 9,296 | $25.23 | $235K | View |
| Nov 2, 2026 | Sold | ADPT | 2,585 | $26.34 | $68K | View |
| Oct 30, 2026 | Sold | ADPT | 9,486 | $26.55 | $252K | View |
| Oct 30, 2026 | Sold | ADPT | 2,395 | $27.45 | $66K | View |
| Oct 29, 2026 | Sold | ADPT | 11,881 | $28.27 | $336K | View |
| Oct 28, 2026 | Sold | ADPT | 11,681 | $28.44 | $332K | View |
| Oct 28, 2026 | Sold | ADPT | 200 | $28.90 | $6K | View |
| Oct 27, 2026 | Sold | ADPT | 3,000 | $26.58 | $80K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8403 | Ottis H. Phillips Director, SmartFinancial. Knoxville, TN | $10.6M |
| 8404 | Thomas P. Gilligan SVP-Human Resources, The Sherwin-Williams. Cleveland, OH | $10.6M |
| 8405 | Michael J. Ahearn Director, First Solar. Phoenix, AZ | $10.6M |
| 8406 | Julie Rubinstein President and COO, Adaptive Biotechnologies. Seattle, WA | $10.6M |
| 8407 | William Tai Director, Hut 8. Miami, FL | $10.6M |
| 8408 | David A. Greenblatt Director, Cavco Industries. Phoenix, AZ | $10.6M |
| 8409 | Martin Bernard Davis EVP & CIO, The Southern. Winter Haven, FL | $10.6M |
Other Adaptive Biotechnologies insiders
All ADPT insiders- Chad M. Robins$58.4MCEO and Chairman. #2282 overall
- Harlan S Robins$22.8MChief Scientific Officer. #4699 overall
- Tycho Peterson$14.9MChief Financial Officer. #6474 overall
- Susan Bobulsky$10.9MChief Commercial Officer, MRD. #8231 overall
- Kyle Piskel$7.2MChief Financial Officer. #11183 overall
- Francis Lo$6.3MChief People Officer. #12386 overall
Questions
How much stock does Julie Rubinstein own?
Julie Rubinstein holds $10,597,346 in listed stock based on SEC filings and current prices, mostly Adaptive Biotechnologies (ADPT). That ranks 8406th on the Stock Rich List.
Is this Julie Rubinstein's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Julie Rubinstein last buy or sell stock?
The most recent open-market trade on file is a sale of 11,466 ADPT shares on Nov 13, 2026 at $28.93.